RxDoctor Payments Data

Thomas Obermeyer, MD

Orthopaedic Surgery · Schaumburg, ILNPI 1700049038

Payments from drug & device makers

$136,467in general payments, 2019–2025

Across 89 payments — averaging $1533.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exactech, Inc.$135K
  • Stryker$733
  • Oak Med, Inc.$146
  • Smith+Nephew$133
  • Boston Scientific$124
  • Encore Medical, LP$121
  • plus $188 from 3 others
$21,340in research payments, 2019–2025

Across 2 payments — averaging $10,670 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Exactech, Inc.$21K

What the payments were for

  • Consulting fees$70,75481%
  • Travel & lodging$12,17214%
  • Food & beverage$4,3765%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exactech, Inc.69$135,021
Stryker12$733
Oak Med, Inc.1$146
Smith+Nephew1$133
Boston Scientific1$124
Encore Medical, LP1$121
Medacta USA, Inc.1$98
Linvatec Corporation2$70
Amgen1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$136,467 in reported general payments places this provider in the 90th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$479,468
Medicare patients
658
Services billed
27,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam306$971
Methylprednisolone160$932
Celecoxib28$776
Mupirocin54$505
Gabapentin42$194
Amoxicillin23$33

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Schaumburg

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →